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Asthma is responsible for a high morbidity, resulting in hospitalizations, recurrent asphyxiation, and eventually death. In Brazil,
where asthma is the third cause of hospitalizations for clinical illnesses and the fourth cause of death from respiratory diseases,
some 20% of the population present wheezing. We evaluated the asthma mortality rates in the period between 1998 and 2009,
using linear regressions, using the National Mortality Database (Ministry of Health of Brazil). The annual mortality rate (per
100,000 inhabitants) ranged from 1.68 in 1998 to 1.32 in 2009 (mean:1.49). Brazil presents a slight tendency of reduction in
asthma mortality. Asthma mortality rates trends declined in the most developed regions of the country: Midwest, South, and
Southeast, but it increased in the underprivileged regions: North (not statistically signiﬁcant) and Northeast. This terrible sort of
inequality requires urgent reaction from the public health authorities.
Asthma is responsible for a high morbidity, resulting in hos-
pitalizations, recurrent asphyxiation, and eventually death.
Worldwide, asthma aﬀects 300 million people most of whom
live in low- and middle-income countries. The epidemic of
asthmaobservedinLatinAmericamaycontinueinthefuture
with increasing urbanization. In Brazil, where asthma is the
third cause of hospitalizations for clinical illnesses and the
fourth cause of death from respiratory diseases, some 20% of
the population present wheezing [1, 2].
We evaluated the asthma mortality rates in the period
between 1998 and 2009, using linear regression or general
linear regression gamma, using the National Mortality
Database (Ministry of Health of Brazil). 31, 843 deaths due
to asthma were registered during this period. The annual
mortality rate (per 100,000 inhabitants) ranged from 1.68 in
1998 to 1.32 in 2009, mean: 1.49 (Figure 1). Brazil presents
a slight tendency of reduction in asthma mortality. Asthma
mortality rates trends declined in the most developed
regions of the country: Midwest, South, and Southeast,
but it increased in the underprivileged regions: North (not
statistically signiﬁcant) and Northeast. Northeast presented
thehighestincreaseinasthmadeathsduringthestudyperiod
(Table 1).
Brazil has the 7th greatest economy worldwide [3].
However, less than 7% of GIP have been invested in health
resources [4]. This proﬁle added to a poor and unsystematic
attention to asthma has resulted in a sharp contrast in the
quality of care for this disease in diﬀerent regions of Brazil.
This terrible sort of inequality requires urgent reaction from
the public health authorities. Asthma control is possible
with simple diagnostic tools and access to recommended
inhaled therapy [5]. Health practices for asthma control
have been adopted in various countries. The examples of
successful programs for asthma control in Finland and
Canada demonstrate that it is possible to signiﬁcantly reduce
morbidity, mortality, and costs caused by the disease using
simple strategies [5].
Since 2002, the Brazilian Ministry of Health have oﬀered
free antiasthmatic medications to severe cases; and this
policy was extended to others forms of the disease since2 The Scientiﬁc World Journal
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Figure 1: Asthma mortality rates due to asthma, per 100,000 inhabitants, in Brazil and in its regions in the period between 1998 and 2009.
Table 1: Mortality rates due to asthma per 100,000 inhabitants in Brazil and in its regions in the period between 1998 and 2009.
Locality 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 Δ(%)2
Brazil 1.68 1.66 1.53 1.48 1.38 1.40 1.43 1.41 1.67 1.51 1.42 1.32 −21.62
North region 1.04 0.87 0.87 0.78 0.70 0.73 0.82 0.77 1.09 0.89 0.98 0.74 −29.01
Northeast region 1.71 1.81 1.69 1.68 1.53 1.59 1.51 1.70 2.24 2.05 1.98 1.77 3.74
Southeast region 1.65 1.67 1.53 1.47 1.38 1.42 1.52 1.36 1.51 1.34 1.24 1.20 −27.34
South region 2.16 1.87 1.71 1.62 1.57 1.56 1.51 1.48 1.65 1.60 1.40 1.39 −35.90
Midwest region 1.43 1.40 1.22 1.19 1.12 1.01 1.06 1.17 1.06 1.01 0.85 0.78 −45.07
1b value according to linear regression with gamma distribution only for b value in Brazil for hole period between 1998 and 2009 (b = −0.016; P = 0.0001).
2Percentual diﬀerence comparing the ﬁrst and last years of analyses (1998 and 2009).
2005. However, access to free medication is not enough,
unfortunately, because the primary health care professionals
are not always prepared to deal with controller therapy of
asthma and inhaled medications are irregularly dispensed
from public pharmacies.
What we, lack however, is the recognition of asthma as a
majorproblem.Weneed toincreaseawarenessofthedisease,
permanently build capacity of the public health system to
improve the diagnosis and to guide regular treatment in
primary care, preserving the regional characteristics and
striving for simplicity.
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